Sign in

CIK 0001360214 · Large accelerated filer

HARROW, INC.

Sign in to watch
Ticker
HROW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
450567010
Phone
615.733.4731
Business address
1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
Former names
HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
  1. DEF 14A Proxy Proxy Statement
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 8-K Event Executive or director change
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. SC 13G Stake Amended Statement of Ownership
  9. 8-K Event Results of operations
  10. 10-K Report Annual Report
  11. SC 13G Stake Amended Statement of Ownership
  12. 4/A Open-market buy 10% owner bought 45,000 shares at $3.60 ($162,000)
  13. 4/A Open-market buy 10% owner bought 45,000 shares at $3.65 ($164,250)
  14. 4 Open-market buy 10% owner bought 45,000 shares at $3.65 ($164,250)
  15. 424B5 Offering Prospectus
  16. 424B5 Offering Prospectus
  17. 8-K Event Material agreement · Other events
  18. 424B5 Offering Prospectus
  19. 8-K Event Results of operations · Regulation FD disclosure
  20. SC 13G/A Stake Amended Statement of Ownership

Page 28 of 44 · 872 filings